Nicoya

Nicoya develops advanced biosensor platforms and analytical instruments for biologics characterization, enabling scientists to gain critical insights into molecular function, structure, and stability. Its technology integrates nanotechnology and microfluidics to provide tools for discovery, characterization, and quality control, supporting reliable and reproducible biophysical analysis. The company’s offerings streamline complex scientific processes for researchers in life sciences.

Founded in 2012 by Ryan Denomme, Nicoya emerged from an initial bold project aimed at making sophisticated scientific tools more accessible. Denomme, an engineer with a passion for discovery, recognized a need to reduce the cost and complexity associated with advanced analytical instrumentation, leading to the development of innovative biosensor solutions for the scientific community.

The company serves a global customer base of scientists across academic institutions and top pharmaceutical companies. Nicoya’s long-term vision is to accelerate scientific breakthroughs by providing accessible, intuitive tools that empower researchers to focus on core discovery, ultimately contributing to the improvement of human life through advanced scientific understanding.